Date(s) - February 25, 2021
7:00 pm EST - 8:30 pm EST
Please join the Fibrolamellar Cancer Foundation for an on-line panel discussion outlining and exploring the current state of treatment and patient care for FLC. Panel experts will include leading oncologists, researchers, and surgeons representing both the adult and pediatric fields.
This panel discussion, part of FCF’s Virtual Research Series, will be conducted as an interactive Zoom webinar and will begin at 7:00 pm Eastern time/4:00 pm Pacific time.
Allison O’Neill, MD
Director, Pediatric Liver Tumor Center of Excellence
Dana-Farber Cancer Institute
Boston Children’s Hospital
James Geller, MD
Director, Liver, Kidney and Retinoblastoma Programs, Cancer and Blood Disease Institute
Director, Advanced Cancer Therapy Network, Cancer and Blood Disease Institute
Director, Pilot Translational Core Grant Program, Center for Clinical and Translational Science and Training
Professor, UC Department of Pediatrics
John Gordan, MD, PhD
Assistant Professor, Hematology and Oncology
Kimberly J. Riehle, MD, FACS, FAAP
Associate Professor of Surgery, Division of Pediatric General and Thoracic Surgery
University of Washington
Seattle Children’s Hospital
Erik Shadde, MD, FACS
Associate Professor, Department of Surgery
Division of Abdominal Transplantation
Division of Surgical Oncology
Rush Medical College
Any fibrolamellar patients, caregivers and others interested in learning about the current state of FLC treatment options are invited. Medical and fibrolamellar research professionals are welcome as well.
This event has already been completed.
To view a recording of the event, click here.